ARCHIVES

Ilex Oncology Buys Symphar, Controls Drug For Bone Mets.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

New Risk Stratification Method For Prostate Cancer Described

November 28, 2003

HHS Inspector General: Busy Signals Greet One In Three Callers To 800-4-CANCER

July 24, 1998

The March Attracts Thousands To Rally For Research Funding, Access To Care

October 2, 1998

Biggest NCI Budget Brings Large Headache: More Commitments, Rising Costs, Opportunities

December 8, 1989

In Brief: Moffitt Cancer Center Awarded Core Grant; Biotech Industry Honors Jeffords, Bliley

May 29, 1998

House subcommittee’s 5.6% Increase For NIH includes $2.5 Billion for NCI

July 18, 1997